Potential mechanisms for the enhancement of HERG K + channel function by phospholipid metabolites

British Journal of Pharmacology

Volumn 141, Issue 4, 2004, Pages 586-599

  Wang, Jingxiong ^a,b   Zhang, Yiqiang ^a,b   Wang, Huizhen ^a   Han, Hong ^a   Nattel, Stanley ^a,b,c   Yang, Baofeng ^d   Wang, Zhiguo ^a,b  

^a MONTREAL HEART INSTITUTE   (Canada)

^b UNIVERSITÉ DE MONTRÉAL   (Canada)

^c MCGILL UNIVERSITY   (Canada)

^d HARBIN MEDICAL UNIVERSITY   (China)

Author keywords

1 palmitoyl lysophosphatidsylcholine; 1 palmitoyl lysophosphatidylglycerol; HERG; Lysophospholipids; Oxidative stress; Phosphatidylinositol 4,5 bisphosphate; Protein kinase C; Vitamin E

Indexed keywords

1 PALMITOYLLYSOLECITHIN; 2 PALMITOYLLYSOPHOSPHATIDYLGLYCEROL; ALPHA TOCOPHEROL; HYDROCARBON; LYSOPHOSPHOLIPID; PHOSPHATIDYLCHOLINE; PHOSPHATIDYLGLYCEROL; PHOSPHATIDYLINOSITOL 4,5 BISPHOSPHATE; PHOSPHOLIPID; POTASSIUM CHANNEL; POTASSIUM CHANNEL HERG; POTASSIUM ION; PROTEIN KINASE C; SUPEROXIDE; UNCLASSIFIED DRUG; XANTHINE; XANTHINE OXIDASE;

ACTION POTENTIAL; ARTICLE; CONTROLLED STUDY; ELECTRIC POTENTIAL; HEART ARRHYTHMIA; HEART MUSCLE ISCHEMIA; HUMAN; HUMAN CELL; MOLECULAR INTERACTION; PATCH CLAMP; PHOSPHOLIPID METABOLISM; PRIORITY JOURNAL; RISK ASSESSMENT; SIGNAL TRANSDUCTION; STRUCTURE ACTIVITY RELATION;

ANTIOXIDANTS; CELL LINE; ETHER-A-GO-GO POTASSIUM CHANNELS; HUMANS; HYDROCARBONS; KINETICS; LYSOPHOSPHATIDYLCHOLINES; MEMBRANE POTENTIALS; PATCH-CLAMP TECHNIQUES; PHOSPHATIDYLINOSITOL 4,5-DIPHOSPHATE; PHOSPHOLIPIDS; POTASSIUM CHANNEL BLOCKERS; POTASSIUM CHANNELS; POTASSIUM CHANNELS, VOLTAGE-GATED; PROTEIN KINASE C; SIGNAL TRANSDUCTION; STIMULATION, CHEMICAL; STRUCTURE-ACTIVITY RELATIONSHIP; VITAMIN E;

EID: 1842577760     PISSN: 00071188     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.bjp.0705646     Document Type: Article

References (46)

1. AHUMADA, G.C., BERGMANN, S.R., CARLSON, E., CORR, P.B. & SOBEL, B.E. (1979). Augmentation of cyclic AMP content induced by lysophosphatidyl choline in rabbit hearts. Cardiovasc. Res., 13, 377-382.
2. AIELLO, E.A., JABR, R.I. & COLE, W.C. (1995). Arrhythmia and delayed recovery of cardiac action potential during reperfusion after ischemia. Role of oxygen radical-induced no-reflow phenomenon. Circ. Res., 77, 153-162.
3. BARRINGTON, P.L., MEIER JR, C.F. & WEGLICKI, W.B. (1988). Abnormal electrical activity induced by free radical generating systems in isolated cardiocytes. J. Mol. Cell. Cardiol., 20, 1163-1178.
4. BASSA, B.V., ROH, D.D., VAZIRI, N.D., KIRSCHENBAUM, M.A. & KAMANNA, V.S. (1999). Lysophosphatidylcholine activates mesangial cell PKC and MAP kinase by PLCgamma-1 and tyrosine kinase-Ras Pathways. Am. J. Physiol., 277, F328-F337.
5. BERUBE, J., CAOUETTE, D. & DALEAU, P. (2001). Hydrogen peroxide modifies the kinetics of HERG channel expressed in a mammalian cell line. J. Pharmacol. Exp. Ther., 297, 96-102.
6. + channel activity is regulated by changes in phosphatidyl inositol 4,5-bisphosphate. Circ. Res., 89, 1168-1176.
7. BURNASHEV, N.A., UNDROVINAS, A.I., FLEIDERVISH, I.A., MAKIELSKI, J.C. & ROSENSHTRAUKH, L.V. (1991). Modulation of cardiac sodium channel gating by lysophosphatidylcholine. J. Mol. Cell. Cardiol., 23 (Suppl. 1), 23-30.
8. CORR, P.B., YAMADA, K.A., CREER, M.H., SHARMA, A.D. & SOBEL, B.E. (1987). Lysophosphoglycerides and ventricular fibrillation early after onset of ischemia. J. Mol. Cell. Cardiol., 19 (Suppl. 5), 45-53.
9. CORR, P.B., YAMADA, K.A., CREER, M.H., WU, J., MCHOWAT, J. & YAN, G.-X. (1995). Amphipathic lipid metabolites and arrhythmias during ischemia. In: Cardiac Electrophysiology: From Cell to Bedside, ed. Zipes, D.P. & Jalife, J. pp. 182-203. Philadelphia: WB Saunders.
10. CHOY, P.C., TRAN, K., HATCH, G.M. & KROEGER, E.A. (1997). Phospholipid metabolism in the mammalian heart. Prog. Lipid Res., 36, 85-101.
11. CLARKSON, C.W. & TEN EICK, R.E. (1983). On the mechanism of lysophosphatidylcholine-induced depolarization of cat ventricular myocardium. Circ. Res., 52, 543-556.
12. + channel by dual pathways. Curr. Biol., 10, 671-674.
13. DATORRE, S.D., CREER, M.H., POGWIZD, S.M. & CORR, P.B. (1991). Amphathic lipid metabolites and their relation to arrhythmogenesis min the ischemic heart. J. Mol. Cell. Cardiol., 23 (Suppl. I), 11-22.
14. FAZEKAS, T., NEMETH, M., PAPP, J.G. & SZEKERES, L. (1992). Electrophysiological changes induced by lysophosphatidylcholine, an ischaemic phospholipid catabolite, in rabbit atrial and ventricular cardiac cells. Acta Physiol. Hung., 79, 261-272.
15. FEDIDA, D., BRAUN, A.P. & GILES, W.R. (1993). Alpha 1-adrenoceptors in myocardium: functional aspects and transmembrane signaling mechanisms. Physiol. Rev., 73, 469-487.
16. GINSBURG, I., WARD, P.A. & VARANI, J. (1989). Lysophosphatides enhance superoxide responses of stimulated human neutrophils. Inflammation, 13, 163-174.
17. GOLDHABER, J.I., DEUTSCH, N., ALEXANDER, L.D. & WEISS, J.N. (1998). Lysophosphatidylcholine and cellular potassium loss in isolated rabbit ventricle. J. Cardiovasc. Pharmacol. Ther., 3, 37-42.
18. GROSS, R.W., CORR, P.B., LEE, B.I., SAFFITZ, J.E., CRAFFORD JR, W.A. & SOBEL, B.E. (1982). Incorporation of radiolabeled lysophosphatidyl choline into canine purkinje fibers and ventricular muscle. Electrophysiological, biochemical, and autoradiographic correlations. Circ. Res., 51, 27-36.
19. HATCH, G.M., O, K. & CHOY, P.C. (1989). Regulation of phosphatidylcholine metabolism in mammalian hearts. Biochem. Cell. Biol., 67, 67-77.
20. KIEHN, J., KARLE, C., THOMAS, D., YAO, X., BRACHMANN, J. & KUBLER, W. (1998). HERG potassium channel activation is shifted by phorbol esters via protein kinase A-dependent pathways. J. Biol. Chem., 273, 25285-25291.
21. KINNAIRD, A.A., CHOY, P.C. & MAN, R.Y. (1988). Lysophosphatidylcholine accumulation in the ischemic canine heart. Lipids, 23, 32-35.
22. KIYOSUE, T., AOMINE, M. & ARITA, M. (1984). Lysophosphatidylcholine decreases single channel conductance of inward rectifier k channel in mammalian ventricular myocytes. Jpn. J. Physiol., 34, 369-373.
23. LIU, E., GOLDHABER, J.I. & WEISS, J.N. (1991). Effects of lysophosphatidylcholine on electrophysiological properties and excitation-contraction coupling in isolated guinea pig ventricular myocytes. J. Clin. Invest., 88, 1819-1832.
24. LIU, S.Y., YU, C.H., HAYS, J.A., PANAGIA, V. & DHALLA, N.S. (1997). Modification of heart sarcolemmal phosphoinositide pathway by lysophosphatidylcholine. Biochim. Biophys. Acta, 1349, 264-274.
25. LUNDBÆK, J.A. & ANDERSEN, O.S. (1994). Lysophospholipids modulate channel function by altering the mechanical properties of lipid bilayer. J. Gen. Physiol., 104, 645-673.
26. 2+ transport in streptozotocin-induced diabetic cardiomyopathy in rats. Am. J. Physiol., 253, E202-E207.
27. MAN, R.Y. (1988). Lysophosphatidylcholine-induced arrhythmias and its accumulation in the rat perfused heart. Br. J. Pharmacol., 93, 412-416.
28. MOTLEY, E.D., KABIR, S.M., GARDNER, C.D., EGUCHI, K., FRANK, G.D., KUROKI, T., OHBA, M., YAMAKAWA, T. & EGUCHI, S. (2002). Lysophosphatidylcholine inhibits insulin-induced Akt activation through protein kinase C-alpha in vascular smooth muscle cells. Hypertension, 39, 508-512.
29. MOUTON, R., HUISAMEN, B. & LOCHNER, A. (1991). The effect of ischaemia and reperfusion on sarcolemmal inositol phospholipid and cytosolic inositol phosphate metabolism in the isolated perfused rat heart. Mol. Cell. Biochem., 105, 127-135.
30. NICHOLS, J.W. & PAGANO, R.E. (1981). Kinetics of soluable lipid monomer diffusion between vesicles. Biochemistry, 20, 2783-2789.
31. NISHIOKA, H., HORIUCHI, H., ARAI, H. & KITA, T. (1998). Lysophosphatidylcholine generates superoxide anions through activation of phosphatidylinositol 3-kinase in human neutrophils. FEBS Lett., 441, 63-66.
32. OHARA, Y., PETERSON, T.E., ZHENG, B., KUO, J.F. & HARRISON, D.G. (1994). Lysophosphatidylcholine increases vascular superoxide anion production via protein kinase C activation. Arterioscler. Thromb., 14, 1007-1013.
33. PROKAZOVA, N.V., ZVEZDINA, N.D. & KOROTAEVA, A.A. (1998). Effect of lysophosphatidylcholine on transmembrane signal transduction. Biochemistry (Moscow), 63, 31-37.
34. SAFFITZ, J.E., CORR, P.B., LEE, B.I., GROSS, R.W., WILLIAMSON, E.K. & SOBEL, B.E. (1984). Pathophysiologic concentrations of lysophosphoglycerides quantified by electron microscopic autoradiography. Lab. Invest., 50, 278-286.
35. Kr potassium channel. Cell, 81, 299-307.
36. + channels of guinea-pig ventricular myocytes. Cardiovasc. Drugs Ther., 7 (Suppl. 3), 575-584.
37. + channels by reactive oxygen species. Proc. Natl. Acad. Sci. U.S.A., 94, 11698-11703.
38. + channels as pharmacological targets: present and future implications. Biochem. Pharmacol., 55, 1741-1746.
39. TAKESHITA, S., INOUE, N., GAO, D., RIKITAKE, Y., KAWASHIMA, S., TAWA, R., SAKURAI, H. & YOKOYAMA, M. (2000). Lysophosphatidylcholine enhances superoxide anions production via endothelial NADH/NADPH oxidase. J. Atheroscler. Thromb., 7, 238-246.
40. UNDROVINAS, A.I., FLEIDERVISH, I.A. & MAKIELSKI, J.C. (1992). Inward sodium current at resting potentials in single cardiac myocytes induced by the ischemic metabolite lysophosphatidylcholine. Circ. Res., 71, 1231-1241.
41. + channel function. Circulation, 104, 2645-2648.
42. + currents via different signaling pathways in canine ventricular myocytes. J. Biol. Chem., 276, 40811-40816.
43. WANG, Z., FERMINI, B. & NATTEL, S. (1993). Delayed rectifier outward current and repolarization in human atrial myocytes. Circ. Res., 73, 276-285.
44. + channels expressed in HEK293 cells requires basal protein kinase B activity. FEBS Lett., 534, 125-132.
45. + channel function by hypoglycemia and hyperglycemia: similar phenotypes but different mechanisms. J. Biol. Chem., 278, 10417-10426.
46. ZHOU, Z., GONG, Q., YE, B., FAN, Z., MAKIELSKI, J.C., ROBERTSON, G.A. & JANUARY, C.T. (1998). Properties of HERG channels stably expressed in HEK 293 cells studied at physiological temperature. Biophys. J., 74, 230-241.